Latest Insider Transactions at Catalyst Biosciences, Inc. (CBIO)
This section provides a real-time view of insider transactions for Catalyst Biosciences, Inc. (CBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CATALYST BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CATALYST BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Nassim Usman |
SELL
Open market or private sale
|
Direct |
3,452
-67.85%
|
$41,424
$12.0 P/Share
|
|
Jun 28
2024
|
Nassim Usman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,452
+40.42%
|
$20,712
$6.93 P/Share
|
|
May 01
2024
|
Nassim Usman |
SELL
Open market or private sale
|
Direct |
20,000
-49.62%
|
$280,000
$14.8 P/Share
|
|
May 01
2024
|
Nassim Usman |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+48.04%
|
$120,000
$6.93 P/Share
|
|
Apr 01
2024
|
Nassim Usman |
SELL
Open market or private sale
|
Direct |
20,000
-92.44%
|
$320,000
$16.15 P/Share
|
|
Apr 01
2024
|
Nassim Usman |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+48.04%
|
$120,000
$6.93 P/Share
|
|
Mar 15
2024
|
Nassim Usman |
SELL
Open market or private sale
|
Direct |
20,000
-92.44%
|
$340,000
$17.26 P/Share
|
|
Mar 15
2024
|
Nassim Usman |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+48.04%
|
$120,000
$6.93 P/Share
|
|
Oct 30
2023
|
Ying Luo |
BUY
Other acquisition or disposition
|
Indirect |
2,840,376
+50.0%
|
-
|
|
Oct 30
2023
|
Gni Group Ltd. |
BUY
Other acquisition or disposition
|
Indirect |
63,588,119
+49.84%
|
-
|
|
Oct 27
2023
|
Gni Hong Kong LTD |
SELL
Other acquisition or disposition
|
Direct |
5,371,304
-100.0%
|
-
|
|
Aug 31
2023
|
Augustine Lawlor |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
24
-100.0%
|
-
|
|
Aug 31
2023
|
Augustine Lawlor |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24
-100.0%
|
-
|
|
Aug 31
2023
|
Gni Group Ltd. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,266
-100.0%
|
-
|
|
Aug 31
2023
|
Andrea Hunt |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28
-100.0%
|
-
|
|
Aug 31
2023
|
Nassim Usman |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9
-100.0%
|
-
|
|
Aug 31
2023
|
Nassim Usman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24
-100.0%
|
-
|
|
Aug 31
2023
|
Seline E. Miller SVP Finance; Interim CFO & PAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6
-100.0%
|
-
|
|
Aug 09
2022
|
Nassim Usman |
BUY
Open market or private purchase
|
Direct |
3,250
+11.69%
|
$0
$0.47 P/Share
|
|
Aug 09
2022
|
Seline E. Miller SVP Finance; Interim CFO & PAO |
BUY
Open market or private purchase
|
Direct |
3,250
+33.33%
|
$0
$0.47 P/Share
|
|
Aug 09
2022
|
Grant E. Blouse Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
3,250
+25.66%
|
$0
$0.47 P/Share
|
|
Feb 09
2022
|
Grant E. Blouse Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
3,250
+34.51%
|
$0
$0.46 P/Share
|
|
Feb 09
2022
|
Seline E. Miller SVP Finance; Interim CFO & PAO |
BUY
Open market or private purchase
|
Direct |
3,250
+50.0%
|
$0
$0.46 P/Share
|
|
Feb 09
2022
|
Nassim Usman |
BUY
Open market or private purchase
|
Direct |
3,250
+13.24%
|
$0
$0.46 P/Share
|
|
Jan 07
2022
|
Andrea Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
7,521
+21.04%
|
-
|
|
Jan 07
2022
|
Geoffrey M.D. Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,855
+28.79%
|
-
|
|
Jan 07
2022
|
Eddie Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,308
+26.13%
|
-
|
|
Oct 01
2021
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,588
+10.75%
|
-
|
|
Oct 01
2021
|
Andrea Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
1,824
+8.1%
|
-
|
|
Oct 01
2021
|
Augustine Lawlor |
BUY
Grant, award, or other acquisition
|
Direct |
5,839
+19.2%
|
-
|
|
Oct 01
2021
|
Geoffrey M.D. Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+13.11%
|
-
|
|
Oct 01
2021
|
Eddie Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,980
+11.7%
|
-
|
|
Aug 09
2021
|
Grant E. Blouse Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
1,163
+28.5%
|
$3,489
$3.62 P/Share
|
|
Aug 09
2021
|
Howard Levy Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
639
+50.0%
|
$1,917
$3.62 P/Share
|
|
Aug 09
2021
|
Nassim Usman |
BUY
Open market or private purchase
|
Direct |
867
+4.59%
|
$2,601
$3.62 P/Share
|
|
Jul 01
2021
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,406
+11.5%
|
-
|
|
Jul 01
2021
|
Andrea Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
2,886
+13.26%
|
-
|
|
Jul 01
2021
|
Augustine Lawlor |
BUY
Grant, award, or other acquisition
|
Direct |
5,542
+22.83%
|
-
|
|
Jul 01
2021
|
Geoffrey M.D. Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,713
+14.44%
|
-
|
|
Jul 01
2021
|
Eddie Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,414
+6.76%
|
-
|
|
Apr 05
2021
|
Nassim Usman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.55%
|
$20,000
$4.63 P/Share
|
|
Apr 01
2021
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,926
+11.37%
|
-
|
|
Apr 01
2021
|
Andrea Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
2,480
+13.42%
|
-
|
|
Apr 01
2021
|
Augustine Lawlor |
BUY
Grant, award, or other acquisition
|
Direct |
4,761
+26.52%
|
-
|
|
Apr 01
2021
|
Geoffrey M.D. Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,331
+14.85%
|
-
|
|
Apr 01
2021
|
Eddie Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+6.29%
|
-
|
|
Feb 09
2021
|
Howard Levy Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
1,670
+6.66%
|
$6,680
$4.81 P/Share
|
|
Feb 09
2021
|
Nassim Usman |
BUY
Open market or private purchase
|
Direct |
582
+4.56%
|
$2,328
$4.81 P/Share
|
|
Jan 05
2021
|
Errol B Desouza Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,129
+9.67%
|
-
|
|
Jan 05
2021
|
Andrea Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
1,881
+12.22%
|
-
|